Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Clinical trial NCT06529822 · RECRUITING

Trial details

NCT number: NCT06529822
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Carcinoma Gastroesophageal Adenocarcinoma Melanoma Non-small Cell Lung Cancer

Start date: 2025-03-20
Primary completion: 2030-01-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.